Palatin Technologies
Utility Patent Applications

Last updated:

List of all Palatin Technologies patents 7 in total

Status Patent
Application
Utility: Orally Active Melanocortin Receptor-4 Compounds External link
Filling date: 9 Sep 2025 Issue date: 30 Jun 2022
Application
Utility: Melanocortin Receptor-Specific Peptide Formulations and Methods for Gastrointestinal Tract-Specific Delivery External link
Filling date: 9 Sep 2025 Issue date: 24 Mar 2022
Application
Utility: USE OF BREMELANOTIDE IN PATIENTS WITH CONTROLLED HYPERTENSION External link
Filling date: 9 Sep 2025 Issue date: 22 Jul 2021
Application
Utility: Orally Active Melanocortin Receptor-4 Compounds External link
Filling date: 9 Sep 2025 Issue date: 1 Jul 2021
Application
Utility: USES OF BREMELANOTIDE IN THERAPY FOR FEMALE SEXUAL DYSFUNCTION External link
Filling date: 9 Sep 2025 Issue date: 4 Mar 2021
Application
Utility: Melanocortin-1 Receptor-Specific Peptides for Cytokine Storm and Inflammation Therapy External link
Filling date: 9 Sep 2025 Issue date: 29 Oct 2020
Application
Utility: Therapies for Obesity, Diabetes and Related Indications External link
Filling date: 9 Sep 2025 Issue date: 3 Sep 2020

Showing 1 to 7 of 7 patents.